Apyx Medical Corp (APYX) (Q3 2026) Earnings Call Highlights: Surgical Aesthetics Surge Drives ...
Apyx Medical Corp (APYX) posts $14 million in Q3 2026 revenue as AYON and Renuvion demand lifts Surgical Aesthetics 17%, achieving trailing 12-month positive EBITDA. Related Stocks: APYX ,